文献速递神经MR

美国神经放射学会会员关于颅内血管壁MRI使用与价值的调查

Survey of the American Society of Neuroradiology Membership on the Use and Value of Intracranial Vessel Wall MRI.
PubMed 文献 · AJNR Am J Neuroradiol · 2022-06-16

该调查于2019年4月2日至8月30日发放给美国神经放射学会会员,最终纳入411份回复;52%的机构开展颅内血管壁MRI,最常用于血管病鉴别(94.4%),未开展者主要障碍为判读(53.1%)和技术(46.4%)专长不足。

要点

  • 52%的机构开展颅内血管壁MRI,71.5%每月至少1-2次,87.7%使用3D序列。
  • 最常见适应证为血管病鉴别(94.4%)、隐源性卒中(41.3%)、动脉瘤(38.0%)。
  • 未开展者主要障碍为判读(53.1%)或技术(46.4%)专长不足。

核心结论

  • 超过50%的神经放射学机构使用血管壁MRI进行颅内血管病的特征描述和鉴别,强调需要额外的技术和教育支持。

研究设计与样本

  • 美国神经放射学会血管壁成像研究组调查,2019年4月2日至8月30日发放,共532份回复,排除79份未回复和42份重复机构回复后纳入411份。

诊断标准与关键数值

  • 52%的机构开展血管壁MRI,其中71.5%每月至少进行1-2次,多数在3T MR成像上进行,87.7%使用3D序列。
  • 方案最常包括T1加权平扫和增强以及TOF-MRA;60.6%的机构供应商贡献有限或仍处于方案开发阶段。
  • 适应证:血管病鉴别94.4%、隐源性卒中41.3%、动脉瘤38.0%、动脉粥样硬化37.6%。

临床应用与阅片要点

  • 未开展血管壁MRI的机构中,若克服技术/专长障碍,56.4%表示将会开展。
  • 申请提供者最常询问血管壁MRI的来自卒中神经科(56.5%)和神经外科(25.1%),34.3%表示无提供者询问。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Intracranial vessel wall MR imaging is an emerging technique for intracranial vasculopathy assessment. Our aim was to investigate intracranial vessel wall MR imaging use by the American Society of Neuroradiology (ASNR) members at their home institutions, including indications and barriers to implementation.

MATERIALS AND METHODS: The ASNR Vessel Wall Imaging Study Group survey on vessel wall MR imaging use, frequency, applications, MR imaging systems and field strength used, protocol development approaches, vendor engagement, reasons for not using vessel wall MR imaging, ordering-provider interest, and impact on clinical care, was distributed to the ASNR membership between April 2 and August 30, 2019.

RESULTS: There were 532 responses; 79 were excluded due to nonresponse and 42 due to redundant institutional responses, leaving 411 responses. Fifty-two percent indicated that their institution performs vessel wall MR imaging, with 71.5% performed at least 1-2 times/month, most frequently on 3T MR imaging, and 87.7% using 3D sequences. Protocols most commonly included were T1-weighted pre- and postcontrast and TOF-MRA; 60.6% had limited contributions from vendors or were still in protocol development. Vasculopathy differentiation (94.4%), cryptogenic stroke (41.3%), aneurysm (38.0%), and atherosclerosis (37.6%) evaluation were the most common indications. For those not performing vessel wall MR imaging, interpretation (53.1%) or technical (46.4%) expertise, knowledge of applications (50.5%), or limitations of clinician (56.7%) or radiologist (49.0%) interest were the most common reasons. If technical/expertise obstacles were overcome, 56.4% of those not performing vessel wall MR imaging indicated that they would perform it. Ordering providers most frequently inquiring about vessel wall MR imaging were from stroke neurology (56.5%) and neurosurgery (25.1%), while 34.3% indicated that no providers had inquired.

CONCLUSIONS: More than 50% of neuroradiology groups use vessel wall MR imaging for intracranial vasculopathy characterization and differentiation, emphasizing the need for additional technical and educational support, especially as clinical vessel wall MR imaging implementation continues to grow.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Mossa-Basha, Zhu, Yuan, et al. Survey of the American Society of Neuroradiology Membership on the Use and Value of Intracranial Vessel Wall MRI. AJNR Am J Neuroradiol. 2022. PMID: 35710122. doi:10.3174/ajnr.A7541

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。